Cargando…

Hepatic Steatosis and Fibrosis in Chronic Inflammatory Bowel Disease

Background and Purpose: Chronic inflammatory bowel diseases (IBD) frequently affect extraintestinal organs including the liver. Since limited evidence suggests the presence of liver disease in IBD patients, we studied the frequency of hepatic steatosis and fibrosis in these patients and characterize...

Descripción completa

Detalles Bibliográficos
Autores principales:	Veltkamp, Claudia, Lan, Shuai, Korompoki, Eleni, Weiss, Karl-Heinz, Schmidt, Hartmut, Seitz, Helmut K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9105667/ https://www.ncbi.nlm.nih.gov/pubmed/35566749 http://dx.doi.org/10.3390/jcm11092623

Ejemplares similares

Endoplasmic reticulum stress in hepatic steatosis and inflammatory bowel diseases
por: Guo, Beichu, et al.
Publicado: (2014)

Hepatic Fibrosis and Steatosis in Metabolic Syndrome
por: Gangireddy, Venu Gopala Reddy, et al.
Publicado: (2022)

Inflammatory Mediators of Hepatic Steatosis
por: Hijona, Elizabeth, et al.
Publicado: (2010)

Hepatic steatosis and fibrosis: Non-invasive assessment
por: Karanjia, Rustam N, et al.
Publicado: (2016)

Cardiac diagnostic work-up for atrial fibrillation after transient ischaemic attacks in England and Wales: results from a cross-sectional survey
por: Geraghty, Olivia, et al.
Publicado: (2016)

Predictors of hepatic steatosis in HBeAg-negative chronic hepatitis B patients and their diagnostic values in hepatic fibrosis
por: Zheng, Rui-dan, et al.
Publicado: (2010)

The association of hepatic steatosis and fibrosis with heart failure and mortality
por: Park, Jiyun, et al.
Publicado: (2021)

Insulin Resistance, Steatosis, and Fibrosis in Egyptian Patients with Chronic Hepatitis C Virus Infection
por: Ahmed, Ahlam M., et al.
Publicado: (2011)

Gentiopicroside Ameliorates the Progression from Hepatic Steatosis to Fibrosis Induced by Chronic Alcohol Intake
por: Yang, Hong-Xu, et al.
Publicado: (2020)

Weight Gain and Liver Steatosis in Patients with Inflammatory Bowel Diseases
por: Spagnuolo, Rocco, et al.
Publicado: (2019)

Treating Hepatic Steatosis and Fibrosis by Modulating Mitochondrial Pyruvate Metabolism
por: McCommis, Kyle S., et al.
Publicado: (2018)

TRIF Differentially Regulates Hepatic Steatosis and Inflammation/Fibrosis in Mice
por: Yang, Ling, et al.
Publicado: (2017)

The rs738409 polymorphism of the PNPLA3 gene is associated with hepatic steatosis and fibrosis in Brazilian patients with chronic hepatitis C
por: Manchiero, Caroline, et al.
Publicado: (2017)

Screening for Liver Steatosis and Fibrosis in Patients with Inflammatory Bowel Disease Using Vibration Controlled Transient Elastography with Controlled Attenuation Parameter
por: Trifan, Anca, et al.
Publicado: (2022)

Saroglitazar improved hepatic steatosis and fibrosis by modulating inflammatory cytokines and adiponectin in an animal model of non-alcoholic steatohepatitis
por: Akbari, Rasoul, et al.
Publicado: (2021)

IL-33 treatment attenuated diet-induced hepatic steatosis but aggravated hepatic fibrosis
por: Gao, Yinjie, et al.
Publicado: (2016)

Metabolomic Phenotype of Hepatic Steatosis and Fibrosis in Mexican Children Living with Obesity
por: Garibay-Nieto, Nayely, et al.
Publicado: (2023)

Morphometric Analysis of Hepatic Steatosis in Chronic Hepatitis C Infection
por: Zubair, Alia, et al.
Publicado: (2009)

Extent of white matter lesion is associated with early hemorrhagic transformation in acute ischemic stroke related to atrial fibrillation
por: D'Anna, Lucio, et al.
Publicado: (2021)

Fibrosis in Chronic Hepatitis C: Correlation between Immunohistochemically-Assessed Virus Load with Steatosis and Cellular Iron Content
por: Akl, Maha, et al.
Publicado: (2016)

Clinical usefulness of new noninvasive serum biomarkers for the assessment of liver fibrosis and steatosis in children with chronic hepatitis C
por: Pokorska-Śpiewak, Maria, et al.
Publicado: (2017)

PNPLA3 148M Carriers with Inflammatory Bowel Diseases Have Higher Susceptibility to Hepatic Steatosis and Higher Liver Enzymes
por: Mancina, Rosellina Margherita, et al.
Publicado: (2015)

Clinical and Virological Characteristics of Chronic Hepatitis B Patients with Hepatic Steatosis
por: Zheng, Rui-dan, et al.
Publicado: (2013)

Diagnostic and prognostic significance of hepatic steatosis in patients with chronic hepatitis C
por: Stan, Ionelia Sorina, et al.
Publicado: (2021)

Effect of silibinin capsules combined with lifestyle modification on hepatic steatosis in patients with chronic hepatitis B
por: Lv, Duo-Duo, et al.
Publicado: (2021)

Inhibition of Heme Oxygenase Antioxidant Activity Exacerbates Hepatic Steatosis and Fibrosis In Vitro
por: Raffaele, Marco, et al.
Publicado: (2019)

Lumacaftor/ivacaftor therapy is associated with reduced hepatic steatosis in cystic fibrosis patients
por: Kutney, Katherine, et al.
Publicado: (2019)

Inhibition of chylomicron assembly leads to dissociation of hepatic steatosis from inflammation and fibrosis
por: Xie, Yan, et al.
Publicado: (2021)

Association of serum creatinine with hepatic steatosis and fibrosis: a cross-sectional study
por: Ma, Juan, et al.
Publicado: (2022)

Improvement of hepatic steatosis and fibrosis in diabetes: Which bariatric procedure is more appropriate?
por: Jia, Weiping
Publicado: (2022)

A Significant Effect of Pemafibrate on Hepatic Steatosis and Fibrosis Indexes in Patients With Hypertriglyceridemia
por: Katsuyama, Hisayuki, et al.
Publicado: (2023)

Risk Stratification of Advanced Fibrosis in HIV Patients With Hepatic Steatosis Using the NAFLD Fibrosis and BARD Scores
por: YENDEWA, George A., et al.
Publicado: (2023)

Steatosis and hepatitis C
por: Modaresi Esfeh, Jamak, et al.
Publicado: (2016)

Cancer and hepatic steatosis
por: Paternostro, R., et al.
Publicado: (2021)

PNPLA3 rs738409 Polymorphism Associated with Hepatic Steatosis and Advanced Fibrosis in Patients with Chronic Hepatitis C Virus: A Meta-Analysis
por: Fan, Jia-Hao, et al.
Publicado: (2016)

Prevalence of hepatic steatosis and associated factors in Iranian patients with chronic hepatitis C
por: Poortahmasebi, Vahdat, et al.
Publicado: (2016)

How does hepatic steatosis affect the outcome of patients with chronic hepatitis B?
por: Yu, Jung Hwan, et al.
Publicado: (2019)

Chronic hepatitis B infection with concomitant hepatic steatosis: Current evidence and opinion
por: Shi, Yi-Wen, et al.
Publicado: (2021)

Palmitoleate Induces Hepatic Steatosis but Suppresses Liver Inflammatory Response in Mice
por: Guo, Xin, et al.
Publicado: (2012)

Ultrasound Sample Entropy Imaging: A New Approach for Evaluating Hepatic Steatosis and Fibrosis
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_oregnenu1vd2rajkj6u4996b50